$HRGN
Harvard Apparatus Regenerative Technology Inc

2017 Q4 Form 10-Q Financial Statement

#000114420417064038 Filed on December 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q4
Revenue $0.00 $0.00 $28.00K
YoY Change -100.0% -100.0% 250.0%
Cost Of Revenue $0.00 $0.00 $59.00K
YoY Change -100.0% -100.0% -29.76%
Gross Profit $0.00 $0.00 -$31.00K
YoY Change -100.0% -100.0% -59.21%
Gross Profit Margin -110.71%
Selling, General & Admin $970.0K $888.0K $1.230M
YoY Change -21.14% -5.23% 32.26%
% of Gross Profit
Research & Development $470.0K $2.364M $2.320M
YoY Change -79.74% 6.25% 81.25%
% of Gross Profit
Depreciation & Amortization $80.00K $90.00K $110.0K
YoY Change -27.27% -25.0% -15.38%
% of Gross Profit
Operating Expenses $1.440M $3.252M $3.552M
YoY Change -59.46% 2.85% 60.43%
Operating Profit -$1.440M -$3.252M -$3.583M
YoY Change -59.81% 3.27% 56.46%
Interest Expense $320.0K $10.00K $240.0K
YoY Change 33.33% -90.0%
% of Operating Profit
Other Income/Expense, Net -$110.0K $9.000K $241.0K
YoY Change -145.64%
Pretax Income -$1.230M -$3.243M -$3.342M
YoY Change -63.2% 6.22% 45.94%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.230M -$3.243M -$3.342M
YoY Change -63.2% 6.22% 45.94%
Net Earnings / Revenue -11935.71%
Basic Earnings Per Share
Diluted Earnings Per Share -$608.9K -$1.662M -$3.884M
COMMON SHARES
Basic Shares Outstanding 39.79M shares 17.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.040M $1.310M $2.940M
YoY Change 37.41% -78.2% -60.59%
Cash & Equivalents $4.038M $1.310M $2.941M
Short-Term Investments
Other Short-Term Assets $106.0K $274.0K $212.0K
YoY Change -50.0% 174.0%
Inventory $0.00
Prepaid Expenses $289.0K $94.00K $291.0K
Receivables $0.00 $0.00 $42.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.413M $1.678M $3.486M
YoY Change 26.59% -72.97% -55.77%
LONG-TERM ASSETS
Property, Plant & Equipment $632.0K $880.0K $1.065M
YoY Change -40.66% -10.93% -0.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $632.0K $872.0K $1.065M
YoY Change -40.66% -11.74% -0.84%
TOTAL ASSETS
Total Short-Term Assets $4.413M $1.678M $3.486M
Total Long-Term Assets $632.0K $872.0K $1.065M
Total Assets $5.045M $2.550M $4.551M
YoY Change 10.85% -64.57% -49.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $923.0K $1.210M $962.0K
YoY Change -4.05% 50.68% 169.47%
Accrued Expenses $380.0K $530.0K $1.210M
YoY Change -68.6% -30.26% 303.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.622M $2.076M $2.777M
YoY Change -41.59% -13.89% 324.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.622M $2.076M $2.777M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.622M $2.076M $2.777M
YoY Change -41.59% -13.89% 324.62%
SHAREHOLDERS EQUITY
Retained Earnings -$48.23M -$47.01M -$36.32M
YoY Change 32.81% 42.54% -342.12%
Common Stock $25.00K $398.0K $171.0K
YoY Change -85.38% 132.75% 21.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.423M $477.0K $1.774M
YoY Change
Total Liabilities & Shareholders Equity $5.045M $2.553M $4.551M
YoY Change 10.85% -64.53% -49.18%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q4
OPERATING ACTIVITIES
Net Income -$1.230M -$3.243M -$3.342M
YoY Change -63.2% 6.22% 45.94%
Depreciation, Depletion And Amortization $80.00K $90.00K $110.0K
YoY Change -27.27% -25.0% -15.38%
Cash From Operating Activities -$1.650M -$3.170M -$2.990M
YoY Change -44.82% 51.67% 83.44%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$70.00K
YoY Change -100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.00K -$70.00K
YoY Change -100.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.380M 1.070M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.650M -3.170M -2.990M
Cash From Investing Activities 0.000 -10.00K -70.00K
Cash From Financing Activities 4.380M 1.070M 0.000
Net Change In Cash 2.730M -2.110M -3.060M
YoY Change -189.22% 0.48% 313.51%
FREE CASH FLOW
Cash From Operating Activities -$1.650M -$3.170M -$2.990M
Capital Expenditures $0.00 -$10.00K -$70.00K
Free Cash Flow -$1.650M -$3.160M -$2.920M
YoY Change -43.49% 51.92% 79.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Assets Current
AssetsCurrent
1678000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
3486000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2076000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2777000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
2076000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
2777000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
398000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
171000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47005000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36318000 USD
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47084000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37921000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
477000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1774000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2553000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4551000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42000 USD
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1210000 USD
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
274000 USD
CY2017Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
339000 USD
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
605000 USD
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
94000 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
291000 USD
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
212000 USD
CY2017Q3 us-gaap Revenues
Revenues
0 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2364000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2225000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3252000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
3162000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3252000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5279000 USD
CY2016Q3 us-gaap Revenues
Revenues
26000 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
-3000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7121000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3149000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3243000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3053000 USD
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38969000 shares
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17107000 shares
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3243000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3053000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3243000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3053000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
888000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
937000 USD
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9000 USD
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-96000 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
54000 USD
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
13000 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
57000 USD
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
0 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
13000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2906000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3261000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
660000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10687000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8237000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34443000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15585000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10687000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8237000 USD
CY2017Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2016Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2017Q2 bstg Bid Price Per Share
BidPricePerShare
1.00 USD
CY2017Q2 us-gaap Minimum Net Capital Required1
MinimumNetCapitalRequired1
2500000 USD
CY2017Q3 bstg Warrants To Be Modifiednumber
WarrantsToBeModifiednumber
19043696 shares
CY2016 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0193 pure
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.727 pure
CY2017Q3 bstg Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
4300000 USD
CY2017Q3 bstg Warrants To Be Remeasurednumber
WarrantsToBeRemeasurednumber
1844250 shares
CY2016 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y10M24D
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.76
CY2016Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1560284 shares
CY2016Q4 us-gaap Share Price
SharePrice
0.89
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
339000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
605000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
3787000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
274000 USD
CY2013Q4 bstg Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Biostage, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001563665
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BSTG
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39787615 shares
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39787615 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39787615 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17108968 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17108968 shares
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-660000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
306000 USD
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.850 pure
CY2017Q3 us-gaap Share Price
SharePrice
0.31
bstg Class Of Warrant Or Right Grants In Period Exercise Price
ClassOfWarrantOrRightGrantsInPeriodExercisePrice
0.40
bstg Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.40
CY2017Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.49
bstg Memorandum Of Understandingprivate Placementdescription
MemorandumOfUnderstandingprivatePlacementdescription
On June 26, 2017, the Company entered into a binding Memorandum of Understanding (the “MOU”) with First Pecos, LLC (“First Pecos”), pursuant to which the Company would issue to First Pecos in a private placement (the “Private Placement”) 9,700,000 shares of its common stock at a purchase price of $0.315 per share or, to the extent First Pecos, following the transaction, would own more than 19.9% of the Company’s common stock, shares of a new class of preferred stock of the Company (the “Preferred Stock”) with a per-share purchase price of $1,000.
CY2017Q1 bstg Class Of Warrant Or Right Issuance Cost
ClassOfWarrantOrRightIssuanceCost
385000 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0193 pure
bstg Reclassification Of Warrants To Additional Paid In Capital Upon Modification
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponModification
3746000 USD
bstg Reclassification Of Warrants To Additional Paid In Capital Upon Exercise
ReclassificationOfWarrantsToAdditionalPaidInCapitalUponExercise
581000 USD
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y4M24D
CY2017Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1844250 shares
us-gaap Share Based Compensation
ShareBasedCompensation
591000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1027000 USD
us-gaap Depreciation
Depreciation
334000 USD
us-gaap Depreciation
Depreciation
340000 USD
bstg Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
660000 USD
bstg Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
-306000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-135000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-234000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
246000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
418000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-681000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
465000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9360000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6070000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
225000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-140000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-225000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6801000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4496000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1059000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
349000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7869000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4845000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1631000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1450000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2941000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7456000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1310000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6006000 USD
bstg Fair Value Of Warrant Liability Reclassified To Additional Paidin Capital
FairValueOfWarrantLiabilityReclassifiedToAdditionalPaidinCapital
4327000 USD
bstg Fair Value Of Warrant Liability Reclassified To Additional Paidin Capital
FairValueOfWarrantLiabilityReclassifiedToAdditionalPaidinCapital
0 USD
bstg Issuance Of Warrant In Connection With Issuance Of Common Stock
IssuanceOfWarrantInConnectionWithIssuanceOfCommonStock
3787000 USD
bstg Issuance Of Warrant In Connection With Issuance Of Common Stock
IssuanceOfWarrantInConnectionWithIssuanceOfCommonStock
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
28000 USD
bstg Fair Value Of Warrants Issued To Placement Agent
FairValueOfWarrantsIssuedToPlacementAgent
0 USD
bstg Fair Value Of Warrants Issued To Placement Agent
FairValueOfWarrantsIssuedToPlacementAgent
116000 USD
CY2016Q4 bstg Class Of Warrants Or Rights Outstanding Value
ClassOfWarrantsOrRightsOutstandingValue
1560284 shares
bstg Class Of Warrants Or Rights Granted During Period Value
ClassOfWarrantsOrRightsGrantedDuringPeriodValue
21000000 shares
bstg Class Of Warrants Or Rights Exercised During Period Value
ClassOfWarrantsOrRightsExercisedDuringPeriodValue
2647338 shares
CY2017Q3 bstg Class Of Warrants Or Rights Outstanding Value
ClassOfWarrantsOrRightsOutstandingValue
19912946 shares

Files In Submission

Name View Source Status
0001144204-17-064038-index-headers.html Edgar Link pending
0001144204-17-064038-index.html Edgar Link pending
0001144204-17-064038.txt Edgar Link pending
0001144204-17-064038-xbrl.zip Edgar Link pending
bstg-20170930.xml Edgar Link completed
bstg-20170930.xsd Edgar Link pending
bstg-20170930_cal.xml Edgar Link unprocessable
bstg-20170930_def.xml Edgar Link unprocessable
bstg-20170930_lab.xml Edgar Link unprocessable
bstg-20170930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv481065_10q.htm Edgar Link pending
tv481065_ex31-1.htm Edgar Link pending
tv481065_ex31-2.htm Edgar Link pending
tv481065_ex32-1.htm Edgar Link pending
tv481065_ex32-2.htm Edgar Link pending